Telomir Pharmaceuticals Ownership | Who Owns Telomir Pharmaceuticals?


OverviewFinancialsChart

Telomir Pharmaceuticals Ownership Summary


Telomir Pharmaceuticals is owned by 9.38% institutional investors, 31.50% insiders, and 59.11% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 1.24% of TELO shares.

TELO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTelomir Pharmaceuticals9.38%31.50%59.11%
SectorHealthcare Stocks 487.91%11.08%-398.99%
IndustryBiotech Stocks 307.10%11.11%-218.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de370.08K1.24%$462.60K
Marshall wace, llp75.77K0.25%$94.71K
Bank of new york mellon51.45K0.17%$71.52K
Suncoast equity management51.19K0.17%$71.16K
Hrt financial lp28.89K0.10%$36.00K
Qube research26.51K0.09%$33.14K
Two sigma securities22.91K0.08%$28.64K
Praetorian wealth management20.00K0.07%$27.80K
Resources investment advisors, llc.14.00K0.05%$17.50K
Raymond james financial1.79K0.01%$2.24K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Suncoast equity management51.19K0.01%$71.16K
Praetorian wealth management20.00K0.01%$27.80K
Two sigma securities22.91K0.00%$28.64K
Resources investment advisors, llc.14.00K0.00%$17.50K
Hrt financial lp28.89K0.00%$36.00K
Marshall wace, llp75.77K0.00%$94.71K
Eversource wealth advisors46.00-$58.00
New york state common retirement fund---
Rhumbline advisers---
Beaird harris wealth management---

Top Buyers

HolderShares% AssetsChange
Marshall wace, llp75.77K0.00%75.77K
Hrt financial lp28.89K0.00%28.89K
Qube research26.51K-26.51K
Two sigma securities22.91K0.00%22.91K
Praetorian wealth management20.00K0.01%20.00K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de370.08K--830.49K
Y-intercept (hong kong)---64.42K
Charles schwab investment management---46.41K
Hightower advisors---43.00K
Virtu financial---14.96K

New Positions

HolderShares% AssetsChangeValue
Marshall wace, llp75.77K0.00%75.77K$94.71K
Hrt financial lp28.89K0.00%28.89K$36.00K
Qube research26.51K-26.51K$33.14K
Two sigma securities22.91K0.00%22.91K$28.64K
Praetorian wealth management20.00K0.01%20.00K$27.80K

Sold Out

HolderChange
True wealth design-3.00
Nisa investment advisors-96.00
Russell investments group-104.00
Sterling capital management-148.00
Ameritas investment partners-471.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202542-2,793,154-24.36%96.10%2519.05%1614.29%
Mar 31, 20254213.51%3,694,1737.09%129.12%21-32.26%14-
Dec 31, 20243815.15%3,565,51874.27%1225.25%3239.13%--100.00%
Sep 30, 20243332.00%2,045,931465.97%6463.57%234.55%5150.00%
Jun 30, 202425257.14%361,492352.33%11473.94%22214.29%2-

Insider Transactions Trends


DateBuySell
2025 Q2--
2024 Q4--
2024 Q3--

TELO Ownership FAQ


Who Owns Telomir Pharmaceuticals?

Telomir Pharmaceuticals shareholders are primarily institutional investors at 9.38%, followed by 31.50% insiders and 59.12% retail investors. The average institutional ownership in Telomir Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Telomir Pharmaceuticals falls below.

Who owns the most shares of Telomir Pharmaceuticals?

Telomir Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (370.08K shares, 1.24%), Marshall wace, llp (75.77K shares, 0.25%), and Bank of new york mellon (51.45K shares, 0.17%). Together, they hold 1.67% of Telomir Pharmaceuticals’s total shares outstanding.

Does Blackrock own Telomir Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Telomir Pharmaceuticals.

Who is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Suncoast equity management is Telomir Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 51.19K Telomir Pharmaceuticals shares, valued at 71.16K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools